Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Murphy

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancerRoberto Diaz, Jerry J Jaboin, Manuel Morales-Paliza, et al.
Journal of Pain and Symptom Management|July 18, 2009
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapyBarbara A Murphy, Jennifer L Beaumont, John Isitt, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
Head & Neck|January 12, 2019
Early onset oral tongue squamous cell carcinoma: Associated factors and patient outcomesBenjamin R Campbell, Courtney B Sanders, James L Netterville, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 26, 2023
Frontal and anterior temporal hypometabolism post chemoradiation in head and neck cancer: A real-world PET studySteven Bishay, W Hudson Robb, Trent M Schwartz, et al.
The New England Journal of Medicine|March 14, 2008
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactoseChristine H Chung, Beloo Mirakhur, Emily Chan, et al.
Head & Neck|January 23, 2026
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialBarbara A Murphy, Derek K Smith, Cristina M Kline-Quiroz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomasChristine H Chung, Kim Ely, Loris McGavran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elementsD Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2019
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice GuidelineNoam Yarom, Charles L Shapiro, Douglas E Peterson, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancerRoberto Diaz, Jerry J Jaboin, Manuel Morales-Paliza, et al.
Journal of Pain and Symptom Management|July 18, 2009
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapyBarbara A Murphy, Jennifer L Beaumont, John Isitt, et al.
Cancer Research|August 17, 2006
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinomaChristine H Chung, Joel S Parker, Kim Ely, et al.
Head & Neck|January 12, 2019
Early onset oral tongue squamous cell carcinoma: Associated factors and patient outcomesBenjamin R Campbell, Courtney B Sanders, James L Netterville, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 26, 2023
Frontal and anterior temporal hypometabolism post chemoradiation in head and neck cancer: A real-world PET studySteven Bishay, W Hudson Robb, Trent M Schwartz, et al.
The New England Journal of Medicine|March 14, 2008
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactoseChristine H Chung, Beloo Mirakhur, Emily Chan, et al.
Head & Neck|January 23, 2026
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialBarbara A Murphy, Derek K Smith, Cristina M Kline-Quiroz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomasChristine H Chung, Kim Ely, Loris McGavran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2012
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elementsD Neil Hayes, Amy S Lucas, Tawee Tanvetyanon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2019
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice GuidelineNoam Yarom, Charles L Shapiro, Douglas E Peterson, et al.
Pageof 16